Clinical Trial Update: Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Seretide Evohaler with a generic salmeterol/fluticasone HFA inhaler in asthmatic patients, assessing functional respiratory imaging pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Generic Salmeterol/Fluticasone HFA pMDI (salmeterol/fluticasone)
• Seretide Evohaler (salmeterol/fluticasone)

Snippet

Sponsor: FLUIDDA nv | Conditions: Asthma | Phase 3 | Status: COMPLETED